Caris Life Sciences and HotSpot Therapeutics Announce Collaboration to Advance Precision Medicine Development for Difficult-to-Drug Therapeutic Targets
Preferred Portfolio Partnership with Caris Will Streamline Development of HotSpot’s Portfolio by Integrating Broad Tissue and Liquid Molecular Profiling, Artificial Intelligence Driven Mining of Large Datasets, and Clinical-Translational Innovations to Deliver Novel Allosteric Medicines to Patients.
Source: pressreleasepoint.com